Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSGZ.L Regulatory News (SGZ)

  • There is currently no data for SGZ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New issue announcement

8 Oct 2015 07:00

RNS Number : 6031B
Scotgold Resources Ltd
07 October 2015
 

 

 

SCOTGOLD RESOURCES LIMITED

 

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

SCOTGOLD RESOURCES LIMITED

 

ABN

42 127 042 773

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

1) Ordinary fully paid shares

2) Unlisted Options

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

1) 95,295,889

2) 95,295,889

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

1) Ordinary fully paid shares

2) Options exercisable at £0.01 on or before 30 September 2017.

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

1) Yes

2) Shares issued on exercise of Options will rank equally with existing class of quoted shares

 

 

 

 

5

Issue price or consideration

 

1) $0.013 per share

2) Nil

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

Completion of ongoing technical studies, further exploration and working capital

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

28 November 2014

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

Nil

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

1) 95,295,889

2) 95,295,889

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

See Annexure 1.

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

7 October 2015

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

1,230,688,361

 

 

Ordinary Fully Paid Shares

 

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

3,000,000

 

 

 

Options

Exercise at A$0.08

Expiry 31 March 2022

 

 

 

 

153,161

 

 

 

Options

Exercise at £0.031 Expiry 7 December 2015

7,111,111

 

 

Options

Exercise at £0.045

Expiry 28 March 2016

 

30,000,000

 

 

Options

Exercise at £0.0069 Expiry 22 September 2017

 

95,295,889

Options

Exercise at £0.01 Expiry 30 September 2017

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No plans to pay dividends at this stage

 

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

 

No

 

12

Is the issue renounceable or non-renounceable?

Non-renounceable

 

13

Ratio in which the +securities will be offered

1 new ordinary fully paid share for every 10 existing fully paid shares held together with 1 free attaching option

 

14

+Class of +securities to which the offer relates

Ordinary fully paid shares and options

 

15

+Record date to determine entitlements

4 September 2015

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

17

Policy for deciding entitlements in relation to fractions

 

Rounded down to nearest whole number

 

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

None

 

19

Closing date for receipt of acceptances or renunciations

30 September 2015

 

20

Names of any underwriters

 

 

None

 

21

Amount of any underwriting fee or commission

Nil

 

22

Names of any brokers to the issue

 

 

N/A

 

23

Fee or commission payable to the broker to the issue

N/A

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

N/A

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

 

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

8 September 2015

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

26 August 2015

 

28

Date rights trading will begin (if applicable)

N/A

 

29

Date rights trading will end (if applicable)

 

 

N/A

 

30

How do +security holders sell their entitlements in full through a broker?

N/A

 

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

N/A

 

33

+Despatch date

 

 

8 October 2015

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

+Securities described in Part 1

 

(b)

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: ...................................................... Date: 7 October 2015

(Director/Company secretary)

 

Print name: Peter John Newcomb

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

568,529,569

Add the following:

• Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid +ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

194,965,196 26 November 2014

281,897,707 15 December 2014

95,295,889 7 October 2015

 

 

 

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

NIL

"A"

1,140,688,361

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

171,103,254

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

90,000,000 5 May 2015

"C"

90,000,000

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

171,103,254

Subtract "C"

Note: number must be same as shown in Step 3

90,000,000

Total ["A" x 0.15] - "C"

81,103,254

[Note: this is the remaining placement capacity under rule 7.1]

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

1,140,688,361

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

114,068,836

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

 

Nil

 

"E"

Nil

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

114,068,836

Subtract "E"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.10] - "E"

114,068,836

Note: this is the remaining placement capacity under rule 7.1A

 

For further information

Scotgold Resources Limited Westhouse Securities Limited

Richard Gray Robert Finlay / Alastair Stratton

Chief Executive Officer

Tel: +44 (0)7905 884 021 Tel: +44 (0)20 7601 6100

 

Capital Markets Consultants Vicarage Capital Limited

Simon Rothschild Rupert Williams

Tel +44 (0)7703 167 065 Tel: +44 (0)20 3651 2911

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMRBLTMBTMBLA
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - Scotgold Resources Limited
24th Nov 202310:09 amRNSAppointment of Administrators
22nd Nov 20237:00 amRNSPlanned Appointment of Administrators
8th Nov 20237:00 amRNSDirector Resignation
7th Nov 20238:00 amRNSPotential Administration Appointment
16th Oct 20237:00 amRNSUpdate On Financing Discussions
2nd Oct 202310:18 amRNSPotential Administration Appointment
29th Sep 20237:00 amRNSCorporate Update
19th Sep 20239:10 amRNSMining Review Update
11th Sep 20237:30 amRNSSuspension - Scotgold Resources Limited
11th Sep 20237:00 amRNSGeological review, mine plan and operations update
10th Jul 20237:00 amRNSProduction, Sales & Operations – Q2 2023 & H1 2023
14th Jun 20237:00 amRNSBoard Appointment
7th Jun 20237:00 amRNSInterim CEO Appointment
1st Jun 20237:00 amRNSOperational Update and Director Resignation
15th May 20237:00 amRNSSubscription and Open Offer GBP2 million raised
26th Apr 20237:00 amRNSPosting of Circular
21st Apr 20237:00 amRNSSubscription & Open Offer to raise £1.5-2.0m
5th Apr 20237:00 amRNSOfftake advance & commencement long hole stoping
31st Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20237:00 amRNSInterim Results
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20232:05 pmRNSSecond Price Monitoring Extn
27th Mar 20232:00 pmRNSPrice Monitoring Extension
27th Mar 202311:06 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
27th Mar 20239:05 amRNSSecond Price Monitoring Extn
27th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20237:00 amRNSOperations and Corporate Update
16th Feb 20237:00 amRNSResult of Retail Offer - Capital Raising of £3m
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
10th Feb 20237:00 amRNSResults of Capital Raise
9th Feb 20235:00 pmRNSRetail Offer
9th Feb 20234:42 pmRNSProposed Capital Raising
7th Feb 20239:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20239:05 amRNSSecond Price Monitoring Extn
30th Jan 20239:00 amRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20232:15 pmRNSResults of 2022 Annual General Meeting
19th Jan 20237:00 amRNSQ4 2022 Results and 2023 Outlook
29th Dec 20221:00 pmRNSNotice of AGM
21st Dec 20227:00 amRNSPre-close Q4 2022 – Production Update
21st Dec 20227:00 amRNSFinal Results
19th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.